title: Treatment of panic disorder: focus on paroxetine.
abstract: Panic disorder is a chronic and disabling condition associated with significant morbidity. Treatment of panic disorder has evolved significantly in the past 20 years with the availability of serotonergic antidepressants, including the selective serotonin reuptake inhibitors (SSRIs). Of these, paroxetine was the first to receive an indication for treatment of panic disorder and has been extensively studied in this area. A series of randomized, double-blind, placebo-controlled studies have demonstrated the efficacy and safety of paroxetine treatment of panic disorder, with a majority of patients achieving panic-free status during 12-week studies. Continued treatment with paroxetine results in sustained rates of remission compared with placebo. The combination of paroxetine and cognitive behavioral therapy appears to offer benefits of efficacy and sustained therapeutic response.
authors.affiliation: Center for Anxiety and Traumatic Stress-Related Disorders, Massachusetts General Hospital, Boston, MA 02114, USA. mpollack@partners.org
authors.forename: Mark H
authors.initials: MH
authors.lastname: Pollack
authors.forename: Alicia C
authors.initials: AC
authors.lastname: Doyle
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D006801:Humans; D016584:Panic Disorder / Q000188:drug therapy* / Q000523:psychology; D017374:Paroxetine / Q000627:therapeutic use*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine